| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0007 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |